Table 2. Association between PTX3 and clinical parameters in 824 study participants.
| Parameter | Spearman correlation coefficient | P value |
|---|---|---|
| HbA1c | −0.021 | 0.548 |
| FBG | 0.041 | 0.245 |
| FINS | 0.132 | 0.001 |
| HOMA-IR | 0.067 | 0.071 |
| HOMA-β | 0.054 | 0.143 |
| QUICKI | −0.133 | 0.001 |
| 0h-PG at OGTT | 0.075 | 0.032 |
| 1h-PG at OGTT | 0.086 | 0.014 |
| 2h-PG at OGTT | 0.067 | 0.055 |
| AUCglu at OGTT | 0.092 | 0.009 |
0h-PG, fasting plasma glucose before glucose challenge; 1h-PG, 1 hour postprandial plasma glucose; 2h-PG, 2-hour postprandial plasma glucose; AUCglu, area under the curve of glucose during OGTT; FBG, fasting blood glucose; FINS, fasting insulin; HbA1c, glycated hemoglobin; HOMA-IR, homeostasis model assessment-insulin resistance index; HOMA-β, homeostasis model assessment beta cell function index; OGTT, oral glucose tolerance test; QUICKI, quantitative insulin sensitivity check index.